TB Alliance committed to accessibility of TB therapy in India
Read Time:3 Minute, 18 Second The DCGI (Drug Controller General of India) approved TB drug, pretomanid, for conditional access under the National Tuberculosis Elimination Program (NTEP), can play a significant role towards elimination of highly drug-resistant TB in India Pretomanid is a ‘made in India’ product used as part of a six-month treatment regimen with […]









